Back/KORU Medical Systems to Present Innovations at Piper Sandler Healthcare Conference 2024
medical·November 28, 2024·krmd

KORU Medical Systems to Present Innovations at Piper Sandler Healthcare Conference 2024

ED
Editorial
Cashu Finance·2 min read
TL;DR
  • KORU Medical Systems will showcase innovations, including the FREEDOM Syringe Infusion System, at the upcoming healthcare conference.
  • The FREEDOM system enhances patient independence through self-administration of medication, improving quality of life since 1994.
  • KORU Medical supports biopharmaceutical companies with customized solutions for drug development and clinical trials.

KORU Medical Systems to Showcase Innovations at Upcoming Healthcare Conference

KORU Medical Systems, a leader in medical technology, continues to pave the way for advancements in large volume subcutaneous infusion solutions. The company announces its participation in Piper Sandler’s 36th Annual Healthcare Conference, set for December 5, 2024. During this event, KORU Medical’s management will present the latest developments in their product offerings, particularly focusing on their FREEDOM Syringe Infusion System. This system has been instrumental in enhancing patient quality of life since its initial FDA clearance in 1994, allowing for self-administration of medication, thereby promoting independence among patients who require ongoing treatment.

The FREEDOM Syringe Infusion System comprises several key products, including the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, as well as Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These innovations not only provide efficient drug delivery methods but also ensure patient safety and comfort. KORU Medical’s emphasis on user-friendly design supports patients and healthcare providers alike, facilitating the administration of therapies in both home and clinical settings. The company’s commitment to quality and innovation is evident in its ongoing efforts to refine these technologies for broader applications across various therapeutic areas.

In addition to enhancing patient care, KORU Medical plays a significant role in supporting biopharmaceutical companies through its Novel Therapies business. This division focuses on providing bespoke solutions for feasibility and clinical trials in drug development, demonstrating KORU’s versatility and commitment to advancing healthcare innovation. By customizing the FREEDOM System for different clinical and commercial applications, KORU Medical positions itself as a valuable partner in the biopharmaceutical landscape, addressing the evolving needs of the industry and patients alike.

KORU Medical encourages interested parties to access the live and archived presentation via the Investors section of their website. This strategic engagement in the healthcare conference underscores the company’s dedication to fostering collaboration and sharing knowledge within the medical technology sector, furthering its mission to enhance patient outcomes globally. For more information about KORU Medical and its innovative solutions, visit www.korumedical.com.